Sociodemographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents in France 2021-22.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: ppublish

Résumé

Human Papillomavirus (HPV) vaccine coverage was <50% in France in 2022 and even lower among socially disadvantaged populations. We aimed to evaluate socio-demographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents, and related attitudes and knowledge items. Parents of adolescents attending middle schools across France, who participated in a randomized trial responded to an anonymous baseline survey, conducted between November 2021 and February 2022. We used logistic regression models adjusting for a child's age and sex to explore sociodemographic determinants (including at-home multilingualism, occupational categories, local deprivation index and urbanity) of HPV vaccine awareness, uptake, and intention. Among the 1889 participants from 61 schools, parents working as factory workers/farmers had significantly lower odds of vaccine awareness compared to executives/professionals, both if they reported (OR = 0.07; 0.03-0.15) or not (OR = 0.20; 0.11-0.36) speaking also another language than French at home. Parents in lower occupational categories with multilingual families were less likely to have the intention to vaccinate their child (OR = 0.19; 0.07-0.56). Recent physician visit or vaccine offer was strong positive determinants of awareness, uptake and intention. A substantial gradient across occupational categories was observed for attitudes and knowledge around HPV vaccine usefulness, safety, and accessibility. This study confirms the disparities on HPV vaccine uptake in France and provides insight into mechanisms of social disparities in HPV vaccine awareness, access and intention.

Identifiants

pubmed: 39105306
doi: 10.1080/21645515.2024.2381300
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2381300

Auteurs

Alexia F Rivera (AF)

EHESP French School of Public Health, Paris, France.

Josée M Dussault (JM)

Emerging Disease Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.

Damien Oudin Doglioni (D)

Emerging Disease Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Uni. Grenoble Alpes, Univ. Savoie Mont-Blanc, Grenoble, France.

Sandra Chyderiotis (S)

Emerging Disease Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.

Jonathan Sicsic (J)

Université Paris Cité, Paris, France.

Anne-Sophie Barret (AS)

Santé Publique France, Saint Maurice, France.

Jocelyn Raude (J)

EHESP French School of Public Health, Paris, France.
CNRS, EHESP, Univ. Rennes, Rennes, France.

Aurélie Gauchet (A)

Univ. Savoie Mont Blanc, Univ. Grenoble Alpes, Grenoble, France.

Amandine Gagneux-Brunon (A)

CHU de Saint-Etienne - Service d'infectiologie, Saint-Etienne, France.
Centre International de Recherche en Infectiologie, Team GIMAP, Université de Lyon, Lyon, France.
CNRS, Université Jean Monnet, Université Claude Bernard Lyon 1, Lyon, France.

Sébastien Bruel (S)

Department of General Practice, Faculté de Médecine Jacques Lisfranc, Université Jean Monnet, Université de Lyon, Saint-Etienne, France.
CIC-INSERM 1408, CHU de Saint-Etienne, Saint-Etienne, France.

Morgane Michel (M)

ECEVE, Université Paris Cité, Paris, France.
Publique-Hôpitaux de Paris, Hôpital Robert Debré, Unité d'épidémiologie clinique, Paris, France.

Anne-Sophie Le Duc-Banaszuk (AS)

Centre Régional de Coordination des Dépistages des cancers-Pays de la Loire, Angers, France.

Nathalie Thilly (N)

Université de Lorraine, Nancy, France.
CHRU-Nancy, Département Méthodologie, Promotion, Investigation, Université de Lorraine, Nancy, France.

Judith E Mueller (JE)

EHESP French School of Public Health, Paris, France.
Emerging Disease Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
CNRS, EHESP, Univ. Rennes, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH